According to our previous studies, POLE mutant EC is characterized by a hypermutated phenotype, increased tumor mutation burden, and increased lymphocyte infiltration, all of which are closely associated with the immune response and may lead to more benefits from immunotherapy, resulting in improved disease prognosis. Here, POLE is linked to neoplasm.